Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Testosterone undecanoate + testosterone enanthate is a combination of two long-lasting esterified forms of the androgen and anabolic steroid hormone, testosterone. Both are used primarily as replacement therapy in adult males with conditions associated with a deficiency or absence of endogenous testosterone, such as primary or hypogonadotropic hypogonadism. These esters act as prodrugs that release active testosterone after enzymatic cleavage in the body, thereby restoring physiological levels of the hormone. Testosterone acts by binding to and activating the androgen receptor, promoting development and maintenance of male sexual characteristics, muscle mass, bone density, libido, and other functions dependent on adequate androgen signaling[1][2][5]. The main difference between these esters is their pharmacokinetic profile: enanthate has a shorter half-life than undecanoate; thus they may be combined for tailored duration or onset in clinical practice[4]. Both are available under various brand names worldwide for intramuscular injection (and oral use for undecanoate), but this specific combination is not widely marketed as a fixed-dose product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on testosterone undecanoate + testosterone enanthate.